Lazard Capital Upgrades Meridian Biosciences (VIVO) to Buy, $36 Price Target

July 7, 2011 12:20 PM EDT
Get Alerts VIVO Hot Sheet
Price: $19.75 +2.60%

Rating Summary:
    5 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 5 | New: 58
Trade Now! 
Join SI Premium – FREE
Lazard Capital upgraded shares of Meridian Biosciences (NASDAQ: VIVO) to a Buy rating from Neutral. The firm also changed its price target to $36.

For more ratings news on Meridian Biosciences click here and for the rating history of Meridian Biosciences click here.

Shares of Meridian Biosciences closed at $24.73 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

Lazard